Scientists at the University of Manchester have discovered a potential weakness in cancer's ability to return or become resistant to treatment, by targeting the 'fuel' part of stem cells which allows tumours ...
Nov 25, 2014
4 / 5 (7) | 1
Dalhousie Medical School's Dr. Paola Marignani and her team have successfully tested a combination of drugs that shuts down aggressive, metabolically active HER2-positive breast cancers.
Dec 05, 2014
5 / 5 (4) | 0